Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9243548 | Gastroentérologie Clinique et Biologique | 2005 | 4 Pages |
Abstract
Digestive side effects associated with interferon and ribavirin in the treatment of chronic hepatitis C seem to be non specific. So far, inflammatory bowel diseases have only been rarely described in this context. We report two cases of Crohn's disease which occurred a few months after interferon and ribavirin treatment for chronic hepatitis C. The first case was a 43 year old man treated for 7 months with a interferon and ribavirin combination for chronic hepatitis C who experienced colitis related to Crohn's disease, with the occurrence of articular and cutaneous manifestations. The second case was a 43 year old women treated for 8 months with a pegylated interferon and ribavirin combination for chronic hepatitis C who developed Crohn's disease with right ileo-colic topography and severe evolution requiring an ileo-coecal resection because of the failure of medical treatment. The alpha interferon used for its antiviral action against hepatitis C virus, has complex immuno-modulation effects which could reveal latent Crohn's disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ali Khalil, Damien Lucidarme, Philippe Desurmont, Rima Hamdan-Khalil, Bernard Filoche,